* ADOCIA *
2005 - Rhône-Alpes
Lyon
www.no-website.net Discovery, Drugs
Key words: Growth factors, Natural proteins, Regenerating organs, Osteoporosis, Diabetes, Aging population
Mission: to develop innovative drugs for regenerating organs affected by diseases related to the aging of the population, such as osteoporosis and diabetes
Clients: Pharmaceutical industry
g.soula@adocia.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.: Soula (Gérard) [born 1945]
Sc.Dir.: Soula (Olivier) [born 1970]
Fin.Dir.:
BusDev:
Financers: AGF P.E., Bioam Gestion, Société Générale A.M., Viveris Management, Business angels (Alain Tornier and Jean Deléage) | Turnover (M€) : n.a.
Total funding (M€) : n.a.
Last funding (M€) : 12.0
Focus : Multiple
Position : Proof-of-Concept
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2008 .04 | 1st round-financing : 12.0 M€, by AGF P.E., Société Générale A.M., Bioam Gestion, Vivéris Management | RFINA | [3 years] |
| 2005 .12 | Company founded by Gérard Soula (ex-Flamel Technologies, CEO, during 15 years), and his 2 sons, Olivier (born 1970) and Rémy, initially named PPM (Proteins & Peptides Management) | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|
